SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $12,818,000 | +40.5% | 65,500 | +18.0% | 4.14% | +36.4% |
Q2 2020 | $9,123,000 | +39.1% | 55,500 | -2.5% | 3.03% | +1.5% |
Q1 2020 | $6,557,000 | -10.3% | 56,900 | -11.1% | 2.99% | +13.5% |
Q4 2019 | $7,311,000 | +29.0% | 64,000 | -3.6% | 2.63% | +0.6% |
Q3 2019 | $5,667,000 | +34.4% | 66,400 | +9.0% | 2.62% | +67.6% |
Q2 2019 | $4,215,000 | -5.5% | 60,900 | 0.0% | 1.56% | -5.2% |
Q1 2019 | $4,460,000 | +136.0% | 60,900 | +43.3% | 1.65% | +40.5% |
Q4 2018 | $1,890,000 | -24.8% | 42,500 | 0.0% | 1.17% | -1.8% |
Q3 2018 | $2,513,000 | -10.9% | 42,500 | 0.0% | 1.19% | +10.2% |
Q2 2018 | $2,821,000 | +26.9% | 42,500 | 0.0% | 1.08% | +24.9% |
Q1 2018 | $2,223,000 | -27.8% | 42,500 | -26.1% | 0.87% | -20.1% |
Q4 2017 | $3,077,000 | -1.7% | 57,500 | 0.0% | 1.08% | -10.9% |
Q3 2017 | $3,129,000 | -7.0% | 57,500 | -11.5% | 1.22% | -4.7% |
Q2 2017 | $3,363,000 | -17.7% | 65,000 | 0.0% | 1.28% | -18.3% |
Q1 2017 | $4,086,000 | – | 65,000 | – | 1.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |